Astri Therapeutics Inc is a biotechnology company focused on developing innovative therapies for rare and complex genetic diseases
The company leverages advanced scientific research to create targeted treatments that address the underlying causes of these disorders, with a commitment to improving patient outcomes. Through its dedicated team and state-of-the-art technologies, Astri Therapeutics aims to bring transformative therapies to market, thereby enhancing the quality of life for patients and their families affected by these challenging conditions.
Shares of Lifecore Biomedical, Inc. (NASDAQLFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSEHYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell 1.4% to $0.6449 in pre-market trading.
Morgan Stanley cut VTEX (NYSEVTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
Gainers Crown ElectroKinetics Corp. (NASDAQCRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
